48 results
PRE 14A
LRMR
Larimar Therapeutics Inc
12 Apr 24
Preliminary proxy
6:06am
to Larimar Therapeutics, Inc. (the “Company”) and reduces the environmental impact of our Annual Meeting. The Annual Meeting can be accessed via the Internet … AND COMPOSITION
CRITERIA FOR BOARD MEMBERSHIP
BOARD DIVERSITY
BOARD OVERSIGHT OF COMPANY CULTURE AND ENVIRONMENTAL, SOCIAL AND GOVERNANCE HIGHLIGHTS
DIRECTOR
8-K
EX-1.1
waukbqm xwnehcws0r7
16 Feb 24
Entry into a Material Definitive Agreement
4:06pm
8-K
EX-1.1
dho3mfw85d2g5
14 Sep 22
Entry into a Material Definitive Agreement
9:01am
8-K
EX-10.1
6a0 g1tuu
21 May 21
Entry into a Material Definitive Agreement
9:30am
8-K
EX-10.1
goq2msu 6csudv13
30 Oct 20
Entry into a Material Definitive Agreement
5:02pm
D
el9kklc hr
10 Jun 20
$82.08M in equity, sold $82.08M, 1 investor
1:02pm
D
xt9knqa
10 Jun 20
$80M in equity / securities to be acquired, sold $80M, 24 investors
12:57pm
8-K
yvv0pq8
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
8-K
EX-10.1
te7 k04km
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
8-K
EX-14.1
ns64l azed4umgr
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
DEFM14A
3yzob3 nljrc9
29 Apr 20
Proxy related to merger
3:20pm